BIOLASE Revenue and Competitors

Location

$91.4M

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • BIOLASE's estimated annual revenue is currently $35M per year.(i)
  • BIOLASE's estimated revenue per employee is $83,333
  • BIOLASE's total funding is $91.4M.

Employee Data

  • BIOLASE has 420 Employees.(i)
  • BIOLASE grew their employee count by -1% last year.

BIOLASE's People

NameTitleEmail/Phone
1
VP Regulatory Affairs & Quality AssuranceReveal Email/Phone
2
VP, Human ResourcesReveal Email/Phone
3
VP, Clinical Strategic AlliancesReveal Email/Phone
4
VP, OperationsReveal Email/Phone
5
VP Innovation and Business DevelopmentReveal Email/Phone
6
VP Regulatory Affairs & Quality AssuranceReveal Email/Phone
7
Senior Director, Dental Education & Professional RelationsReveal Email/Phone
8
Director EngineeringReveal Email/Phone
9
Chief Operating OfficerReveal Email/Phone
10
Director Continuous ImprovementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58M231-1%N/AN/A
Add Company

What Is BIOLASE?

BioLase Technology Inc. is a medical technology company operating in one business segment that designs, manufactures and markets advanced dental, cosmetic and surgical laser and related products. The Company\'s primary product, the Waterlase system, precisely cuts hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue and dental structure. Its LaserSmile system is designed to complement the Waterlase, and is used in soft tissue procedures and tooth whitening. BioLase has clearance from the United States Food and Drug Administration (FDA) to market its laser systems in the United States. It also has the approvals necessary to sell its laser systems in Canada, the European Union and other international markets.

keywords:N/A

$91.4M

Total Funding

420

Number of Employees

$35M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BIOLASE News

2022-04-20 - BIOLASE ANNOUNCES 1-FOR-25 REVERSE STOCK SPLIT

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products...

2022-04-19 - StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

Colliers Securities restated a “buy” rating on shares of BIOLASE in a research report on Tuesday, March 22nd. Zacks Investment Research upgraded...

2022-04-17 - BIOLASE (NASDAQ:BIOL) and ZimVie (NASDAQ:ZIMV ...

Get BIOLASE alerts: This table compares BIOLASE and ZimVie's gross revenue, earnings per share and valuation.

2021-09-14 - BIOLASE and Healthy Smiles for Kids of Orange County (Healthy Smiles) Invite California Dental Community to Awareness Reception on Sept. 24

FOOTHILL RANCH, Calif., Sept. 14, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and Healthy Smiles for Kids of Orange County (Healthy Smiles) are inviting dental professionals in the Orange County area to an awareness reception around the shared mission ...

2021-08-31 - BIOLASE Announces Clinical Advisory Partnership with Leading Endodontist Dr. L. Stephen Buchanan

FOOTHILL RANCH, Calif., Aug. 31, 2021 /PRNewswire/ -- Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan that will help expand laser adoption and increase hands-on training programs with one of the glob ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$111.6M4257%N/A
#2
$143.4M425-9%N/A
#3
$136M427-9%$154.4M
#4
$79.4M431-15%$163.2M
#5
$146.5M4342%N/A